PF-Atlas › Clinical Trials › NCT04308317

Tetrandrine Tablets Used in the Treatment of COVID-19

Tetrandrine · Phase 4

Registry ID

NCT04308317

Phase

Phase 4

Status

Unknown

Drug / intervention

Tetrandrine

Sponsor

Henan Provincial People's Hospital

Start

2020-03-05

About this trial

Tetrandrine is evaluated in NCT04308317, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Henan Provincial People's Hospital. Current status: Unknown.

View NCT04308317 on ClinicalTrials.gov →

Explore related

All Tetrandrine trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT04308317 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.